(Newser) -
An experimental drug could drastically decrease the risk of bone breakage in osteoporosis sufferers,
Time reports. Two trials of the drug denosumab in groups at high risk for the disease—men receiving testosterone-depleting treatment for prostate cancer and post-menopausal women—reduced the risk of fracture by more than 50%, with...
More »
